The biotech giant announced today that its cancer drug trebananib combined with chemotherapy paclitaxel extended median progression-free survival in recurrent ovarian cancer patients by 1.8 months compared...
In today’s marketplace, there are tons of metrics shareholders can use to track stocks. A couple of the most innovative are hedge fund and insider trading sentiment.
Let's start with Dyax Corp. (NASDAQ:DYAX). The small drugmaker shed more than a third of its value after posting disappointing quarterly results. Dyax Corp.
In today’s marketplace, there are tons of gauges investors can use to analyze publicly traded companies. Some of the most under-the-radar are hedge fund and insider trading interest.
Since sequestration kicked in on Saturday and The End of The World As We Know It was supposed to materialize, the Dow Jones Industrial Average has packed on an additional 164 points, an almost 1.2% jump...